Macrogenics's average Accounts Receivable for the
three
months ended in Dec. 2023 was $17.84 Mil. Macrogenics's Revenue for the
three
months ended in Dec. 2023 was $9.16 Mil.
Hence, Macrogenics's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 177.63.
The historical rank and industry rank for Macrogenics's Days Sales Outstanding or its related term are showing as below:
MGNX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.53 Med: 73.81 Max: 212.48
Current: 172.49
During the past 13 years, Macrogenics's highest Days Sales Outstanding was 212.48. The lowest was 7.53. And the median was 73.81.
MGNX's Days Sales Outstanding is ranked worse than 80.43% of 889
companies
in the Biotechnology industry
Industry Median: 71.97
vs MGNX: 172.49
Macrogenics's Days Sales Outstanding
increased
from Dec. 2022 (44.91) to Dec. 2023 (177.63).
Warning Sign:
If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.
Macrogenics Days Sales Outstanding Historical Data
The historical data trend for Macrogenics's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Macrogenics's Days Sales Outstanding
For the Biotechnology subindustry, Macrogenics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macrogenics's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Macrogenics's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Macrogenics's Days Sales Outstanding falls into.
Macrogenics Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macrogenics (NAS:MGNX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Macrogenics Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Macrogenics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MGNX has been successfully added to your 